European Quality Improvement Programme for Acute Coronary Syndromes (EQUIP-ACS)

R

Royal Brompton & Harefield NHS Foundation Trust

Status

Unknown

Conditions

Acute Coronary Syndrome

Treatments

Behavioral: Quality Improvement Programme

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT00716430
EQUIP-ACS 1

Details and patient eligibility

About

The main hypothesis to be tested is that the use of a quality improvement programme will lead to measurable improvements in the management of care and use of evidence based treatments for patients presenting to hospital with non-ST elevation acute coronary syndromes.

Enrollment

3,500 estimated patients

Sex

All

Ages

Under 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients with a good clinical history of ACS and at least one of the following:

  • New or transient ST or T wave changes on the ECG consistent with acute myocardial ischaemia
  • Elevation of troponin or other cardiac markers to levels indicative of myocardial necrosis according to local laboratory values

Exclusion criteria

  • Evidence of persistent ST elevation on the ECG
  • Use of early reperfusion therapy
  • Patients >80 years
  • Patients transferred from another hospital

Trial design

3,500 participants in 2 patient groups

QI
Active Comparator group
Description:
Quality Improvement Centres
Treatment:
Behavioral: Quality Improvement Programme
Non-QI
No Intervention group
Description:
No Quality Improvement Programme

Trial contacts and locations

0

Loading...

Central trial contact

Marcus D Flather; Daphne Babalis

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems